Neuron23
A leading clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
Portfolio Items
Post Type Description
Recludix
A leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets.
Star
A biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions
Tmunity
Tmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure
Vega
A clinical stage biotechnology company developing novel, first-in-class therapies for rare blood disorders with overlooked patient needs, starting with von